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Abstract
Scientific collaboration networks are a hallmark of contemporary academic research. Researchers are no longer
independent players, but members of teams that bring together complementary skills and multidisciplinary
approaches around common goals. Social network analysis and co-authorship networks are increasingly used as
powerful tools to assess collaboration trends and to identify leading scientists and organizations. The analysis
reveals the social structure of the networks by identifying actors and their connections. This article reviews the
method and potential applications of co-authorship network analysis in health. The basic steps for conducting
co-authorship studies in health research are described and common network metrics are presented. The application
of the method is exemplified by an overview of the global research network for Chikungunya virus vaccines.
Background
Scientific collaborative networks are a hallmark of con-
temporary academic research. Scientists are no longer
independent players, but members of scientific cooper-
ation networks looking for solutions to social, political,
economic and technological problems, which, usually,
require multidisciplinary approaches [1]. When collabor-
ating, researchers can establish communication net-
works, share ideas, resources and information, generate
and deliver new knowledge, and ultimately create inno-
vations, reducing the cost and increasing the productiv-
ity of research [2].
Collaborative networks are particularly relevant in
health innovation because of its complexity, involving
multiple stakeholders and increasingly dependent on
interdisciplinary research [3]. Given the diverse disciplines
that cut across health innovations, knowledge networks
are needed to address such complex areas [4, 5]. Health
innovation networks are proposed as efficient strategies to
help developing countries to address neglected tropical
disease challenges [6]. Open innovation networks between
industry and academia are critical to accelerate the devel-
opment of appropriate products for the health systems [7].
Recent studies have proposed the use of social network
analysis (SNA) to: (1) support the evaluation of cross-
disciplinary research programs [8]; (2) develop strategic
public policy planning [9]; and (3) strengthen innovation
management in public health systems [10]. Other applica-
tions of SNA include support to organizational competi-
tive intelligence [11] and communication management of
networks for the health innovation system [12].
This article reviews the SNA methodology, as applied
to scientific co-authorship in health research, to assess
collaboration trends, identify leading investigators and
organizations, and explain the influence of external fac-
tors in research collaboration and scientific productivity.
As an example, we have analyzed the global network of
research organizations working with the development of
vaccines against the Chikungunya virus.
Review
Social network analysis
A social network can be defined as a finite set of actors
(or nodes) and the relationships (or links) between them.
It is the presence of this relational information that char-
acterizes a social network, being a critical resource and a
prerequisite for its definition [13, 14]. SNA is a theoretical
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perspective and a set of techniques used to understand and
quantitatively measure these relationships [14]. Its main
feature is the emphasis, not on the characteristics or attri-
butes of the actors, but on the connections between them
[13]. By quantifying the social structure of a network – the
set of nodes and their connections – it is possible to iden-
tify the most important nodes, the formation of groups and
the flow of tangible and intangible resources, among other
information [13, 15].
The choice of nodes to be analyzed depends on the
context in which a given set of data is inserted. These
nodes can be individuals, groups, organizations and even
whole countries. In SNA, each relationship defines a dif-
ferent type of network. A connection between the nodes
can be the shared authorship of a paper, the participa-
tion on the same project or the organization of a scien-
tific event. From the perspective of SNA, relations are
not properties of nodes, but of whole systems.
Co-authorship networks
Scientific collaboration can be defined as the interaction
that takes place within a social context between two or
more scientists, which facilitates the sharing of meaning
and fulfillment of tasks in relation to a mutually shared
goal [1]. Scientists are driven to collaborate due to the op-
portunity to discover new knowledge, the increasing
specialization within science, the complexity of infrastruc-
ture required as well as the need to combine different types
of knowledge and skills to address complex health prob-
lems [1, 16]. Scientific collaboration can also help broaden
the scope of a research project and foster innovation as it
provides access to different disciplines [17].
Co-authorship analysis in science and technology
(S&T) partnerships provides a vision of cooperation pat-
terns between individuals and organizations [18–20].
The co-authorship of a technical document is an official
statement of the involvement of two or more authors or
organizations [20]. Despite the debate about its meaning
and interpretation [17, 21], co-authorship analysis is still
widely used to understand and assess scientific collabor-
ation patterns.
In co-authorship networks, nodes represent authors,
organizations or countries, which are connected when
they share the authorship of a paper [20].
Brief review of the applications of co-authorship analysis
in health research
The analysis of co-authorship networks in health re-
search can be used in different contexts. Morel et al. [9]
suggested that co-authorship analysis could provide rele-
vant scientific information for strategic planning of
health organizations. The authors analyzed the Brazilian
scientific co-authorship networks in six neglected trop-
ical diseases (dengue, Chagas disease, leishmaniasis,
leprosy, malaria and tuberculosis). Through SNA, they
were able to identify key leading organizations that could
act as scientific bridges in the scientific community, the
most active research groups, the public health approach to
these diseases and other relevant information that could
contribute to the management of control programs.
Another application was the evaluation of the relation-
ship between scientific productivity and health techno-
logical development. The analysis of publication and
patent networks in tuberculosis highlighted the active
role of the academic area, but a weak engagement of in-
dustry in Brazil [10]. The authors recommended the
joint analysis of scientific publications and patents in de-
veloping countries, where the same actors are usually in-
volved in both research and technological innovation.
González-Alcaide et al. [22] analyzed global research
collaboration in leishmaniasis. Using SNA, the authors
were able to characterize the collaboration profile, iden-
tify key researchers and countries that had the greatest
role in the network, and observe the cooperation trend
and the development of research groups over time. Ac-
cording to the authors, SNA allows better understanding
of the markedly cooperative organizational and social
context in which scientific knowledge is generated.
Reviewing over 3000 research articles on health man-
agement indexed on the Web of Science database over a
period of 13 years, Zhang et al. [23] showed that, despite
the growing collaborative behaviour in recent years, co-
operation between countries is still incipient and should
be encouraged in order to internationalize and promote
the progress of research in the area. The authors were
able to identify the leading academic researchers in the
field and research organizations that played an essential
role in disseminating information and control of health
management resources.
Naranjo-Estupiñán et al. [24], reviewing co-authorship
networks in public health in Colombia, showed that the
scope of collaboration in epidemiology is more re-
strictive than in social sciences, which has a broader
engagement of collaborators. The analysis allowed the
identification of public health disciplines with poor
collaboration.
A study of scientific collaborative networks in biotech-
nology in the north-eastern region of Brazil [25], showed
that collaboration was primarily intra-institutional, with
limited diversity and marginal representation of the pri-
vate sector, not reflecting the expected role of biotech-
nology as one of the pillars to drive science, technology
and innovation in the region.
The review by Robinson-García et al. [26] of inter-
organizational relationship of Spanish universities in
healthcare allowed the identification of leading univer-
sities, as well as the potential collaboration according to
their publication profile.
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Bender at al. [27] identified and mapped neglected
tropical disease research with an affiliation to Germany.
The authors acknowledged the strong collaborations
between German organizations and partners abroad,
but limited collaboration with low- and middle-income
countries, highlighting the need of engaging in scien-
tific capacity building efforts. Through the analysis of
individual researcher networks, academic talents could
be identified.
Table 1 summarizes the potential applications of
co-authorship network analysis as exemplified before.
Six main objectives and key potential indicators were
identified in the literature. Co-authorship analysis
allowed assessment of the productivity of research
programs, assessment of the relationship between
scientific and technological development, mapping of
priority thematic areas, evaluation of the regional
contribution to knowledge generation, assessment of
inter-organizational networks, and assessment of
international collaboration.
Method description
The three main steps of co-authorship analysis are (1)
retrieval of scientific publications; (2) standardization
of entries for authors and organizations; (3) network
visualization and calculation of metrics; and (4) inter-
pretation of results.
Data retrieval
Publication records are collected from structured biblio-
graphic databases, to allow systematic cleaning and
standardization of data. Ideally, these databases should:
(1)Cover a large number of academic journals and have
high representation of health-related journals;
(2)Provide information on the affiliations of the
authors, allowing the construction of organizational
networks;
(3)Allow the exportation of data in text format
compatible with bibliometric analysis software;
(4)Provide the full name of the authors in most
publications.
In SNA studies, the correct spelling of authors’ names
is critical for accurate and reliable links between them
and consequently for the entire network. The same
author can have different names on records resulting
from abbreviations, omissions, name changes, aliases
and spelling errors, while different authors can have the
same name (homonyms) [28]. These cases can generate
errors, causing links to be falsely aggregated or disaggre-
gated. Large differences were found in metrics between
co-authorship networks comparing full names, short
names or the surname followed by the first initial [29].
The choice of the most appropriate database will de-
pend on the subject of study and on the type of network
Table 1 Main applications of social network analysis and co-authorship networks in health research
Objective Target network Key indicators References
Assess the extent of collaboration
within research programs
Co-authorship in target fields of the
research programs
- Changes in network structure
before and after the program
Morel et al., 2009 [9]
- Central organizations and
researchers
Assess the relationship between scientific
and technological development
Co-authorship in specific themes in parallel
with patent co-inventorship networks




- Differences in the structural
properties of both networks
Map priority thematic areas Co-authorship in priority themes of public
health interest




Zhang et al., 2013 [23]
- Central organizations and
researchers
- Formation of research groups
Evaluate the regional contribution to
knowledge generation
Regional co-authorship in areas of
interest




Costa et al., 2013 [25]
- Central organizations and
researchers
- Frequent partners
Assess inter-organizational networks Co-authorship of science and technology
organizations




Assess international collaboration Co-authorship between countries - Scientific collaboration between
countries
Bender et al., 2015 [27]
- Frequent partners
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investigated. Some of them do not disclose the affilia-
tions of all authors of a paper, which hinders the analysis
of organizations or country networks. Others cover a
wide range of journals, but lack the information about
the full name of authors, which can make the process of
standardization more difficult.
The objective of the analysis and questions to be an-
swered will guide the lag-time of study. In general, there
are two main approaches. The first is based on the prem-
ise that by sharing the authorship of a scientific paper, au-
thors must have been collaborating for some time, during
which exchange of information took place more inten-
sively [30]. A period of up to 5 years has been used to as-
sess the structure of current cooperation [31–33].
A second approach is cumulative networking over an
extended period of analysis. This approach is based on
the assumption that social links between authors persist
over time, even after the end of a formal collaboration
[34]. These cumulative networks are an indication of the
growing social structure that potentially functions as a
network through which relevant knowledge related to
innovation can remain [35].
Publications that have a very large number of authors
should be evaluated carefully as, in some cases, they rep-
resent just independent contributions of data to joint ef-
forts, involving limited intellectual interactions [36].
Standardization and cleaning the data
The step of standardizing and cleaning the retrieved data
can be done manually or using specific software depend-
ing on the volume of the data and/or availability of soft-
ware. The objective is to consolidate names of a particular
author or organization in order to ensure the correct ac-
knowledgement of their scientific production.
After the cleaning process, individual and organizational
co-authorship should be formatted into specific adjacency
matrices, edge lists or adjacency lists, in order to map the
relationships between the nodes. In matrices, the name of
all nodes in the network are entered in both the rows and
columns. When a given pair of nodes share the authorship
of a paper, the number 1 is placed at the intersection be-
tween the two; otherwise, the number 0 is placed at the
intersection. If collaboration occurs more than once, the
number will be equal to the total of papers co-authored.
An edge list is a two-column list of all the node pairs that
are connected. In an adjacency list, the whole set of con-
nections of a single node is listed, beginning with the
source node and ending with the target nodes. Lists are
most useful for representing networks with few links. As
co-authorship requires reciprocal cooperation among the
participants, all connections are considered to be non-
directional.
These data is then imported into a software that allows
not only the visualization of networks but also the
statistical analysis of the data set, such as Gephi [37],
Ucinet [38] and Pajek [39], among others.
Network assembly, metrics and visualization
The statistical analysis in co-authorship networks in-
cludes quantitative metrics that may reflect the proper-
ties of the network as a whole or of its individual nodes.
The choice of which metric to use depends upon the
context and subjects of the analysis.
The metrics at the network level provide information
on its overall structure and properties. Common mea-
surements are (1) the number of nodes and links; (2)
density; (3) centralization; and (4) community structure
of the network. The number of nodes and links repre-
sent the network size. Density is a metric to measure the
connectivity within the network and is defined as the
percentage of the number of existing links in relation to
the maximum number of possible links in a given net-
work [13]. Centralization refers to the degree to which
links are concentrated in one or a few nodes in the net-
work, being useful to evaluate if there are ‘dominant’
nodes in the network. The community structure reflects
the division of a network into groups or modules whose
internal connections are dense and external connections
are sparse [40].
Metrics at the individual level describe the importance
of a node relative to all other nodes in a given network,
taking into account the different ways in which it inter-
acts and communicates with the rest of the network.
Centrality measures are the most used in SNA to iden-
tify the nodes that have strategic significance in the net-
work. The ‘degree centrality’ can be defined as the
number of links that a node has with other nodes. The
more relational ties a node has, the more power or pres-
tige it has in a network. The ‘betweeness centrality’ is
based on the extent to which a particular node lies be-
tween other pairs of nodes in a network, connecting
them. Nodes that are often on the shortest path between
other nodes are deemed ‘central’ because they control
the flow of information in the network by connecting
different groups. ‘Closeness centrality’ is based upon the
degree to which a node is close to all other nodes in the
network. A node is viewed as central to the extent that
it does not depend on others as intermediaries of infor-
mation [41].
Visualization is an important component of SNA. It
gives meaning to the analysis and both complement each
other. Each network actor (individual, institutional, etc.)
is usually displayed as a circle, and its size and/or color
can reflect one or more of its characteristics, such as
centrality, nationality, gender, etc. Network drawing can
be improved for better visibility using spring or force-
based algorithms [14].
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Interpretation of results
The interpretation of the visual display and metrics re-
sults is oriented according to key research questions,
context and information needed. It has the potential to
describe the overall structure of the network, the main
actors and their different roles, the impact of the net-
work on different contexts and the factors that may have
influenced its configuration and evolution. Such infor-
mation can be used to guide funding strategies, for
strengthening and developing new partnerships, identify-
ing knowledge gaps, evaluating national, regional and
international collaboration, mapping priority areas, and
as a benchmark to evaluate research programs.
Example: global research network on vaccines
against the Chikungunya virus
In order to illustrate the application of co-authorship
network analysis in a research area relevant to public
health, we have analyzed the global network of research
organizations working in the development of vaccines
against the Chikungunya virus (CHIKV).
The mosquito-borne CHIKV infection causes a febrile
illness (chikungunya fever) typically accompanied by
rash and severe, debilitating arthralgia [42]. The CHIKV
is considered a high priority emerging infection because
of its mass dissemination potential, high morbidity and
case-fatality rates, and major health impact [43]. So far,
there are limited prospects for controlling CHIKV circu-
lation and many parts of the Americas are now at high
risk of major epidemics [44]. In this analysis, we looked
at recent data available on the global research network
on vaccines against the CHIKV, with particular interest
in S&T organizations.
Data processing
Data was collected from published and ‘in press’ articles
retrieved from the Web of Science (WoS) database, cov-
ering the period 2010–2014. Queries were made in ad-
vanced search mode directed to the topic of research,
which included title, abstract and keywords. The query
was made using the terms "vaccin* AND (chikungunya
OR CHIKV)". The search retrieved 129 papers.
Collected data was imported into the VantagePoint®
software (Search Technology Inc.) using specific filters
for the WoS database. Standardization of the various
record names of an organization was done using the ‘list
cleanup’ function of the software. Treated and cleaned
data were formatted by VantagePoint® into an adjacency
matrix to map co-authorships (co-occurrences). The
matrix was converted into a csv (comma separated
values) file and imported into the Gephi software [37]
for visualization and analysis. In Gephi, the ForceAtlas 2
layout was used for visualization. Three different mea-
sures of centrality were calculated to assess whether an
organization had a prominent or influential role in the
network: degree centrality, betweeness centrality and
closeness centrality.
Networks were created for both collaborating coun-
tries and research organizations using author affiliations
to identify this information. Nodes represented countries
or organizations, and links between them indicate that
their members share the authorship of one or more sci-
entific papers.
Results
Based on the data retrieved, the global research network
for the development of vaccines against CHIKV was
composed of 38 countries, reflecting the solid inter-
national collaborative research efforts for disease con-
trol. The top three most central countries, according to
their degree centrality, were France, Spain and the
United States, as represented by the larger nodes (Fig. 1).
During the 5-year period evaluated, these countries have
collaborated with 26, 21 and 15 partner countries, re-
spectively, and their degree centrality is indicated in
Table 2. Degree centrality is a proxy for collaboration
and not always a measure of the volume of publications.
France, for example, had the highest degree centrality in
the network but it was behind the United States in num-
ber of publications (Table 2). India and Singapore, des-
pite publishing more papers than Spain on this specific
subject (18 and 14 papers, respectively), ranked lower in
degree centrality indicating a more nationally oriented
research. The United States was the country that collab-
orated most with France, as indicated by the increased
thickness of the links connecting them (Fig. 1).
The network of countries reflects the underlying re-
search networks between organizations and research
groups. Mapping of organizations involved in the global
network for research on CHIKV vaccines identified 205
organizations. Academic organizations represent 49.3%,
research institutes 22.9%, industry 10.7%, and hospitals
and medical centres 7.3%. Other types of organizations,
such as government-related institutions and funding
agencies, were also present to a minor extent.
Metrics of the organizational network are shown in
Table 3. The low density and centralization values asso-
ciated with the large number of communities suggest
sparse collaboration patterns among organizations and/
or diverse research interests. These results highlight the
need and opportunity for further development and
strengthening of new collaborations.
According to their degree centrality, the most central
organizations in the network are, in order of importance,
the University of Texas (United States); the National Uni-
versity of Singapore (Singapore); the Singapore Agency for
Science, Technology and Research (ASTAR; Singapore);
the Queensland Institute of Medical Research (Australia)
Fonseca et al. Health Research Policy and Systems  (2016) 14:34 Page 5 of 10
and the French Alternative Energies and Atomic Energy
Commission (CEA; France) (Table 4). Among these cen-
tral organizations, the CEA is the only one collaborating
with all of the other four central institutions. The Queens-
land Institute of Medical Research has collaborations with
the University of Texas and the University of Singapore
cooperates with ASTAR (Fig. 2, top image).
Some organizations that did not rank high on degree
centrality can have central roles based on their betwee-
ness or closeness measures (Table 4). The University of
Munich (Germany) is a clear example of an organization
that is acting as an intermediary (betweeness) linking
two groups of institutions that would not otherwise be
connected (Fig. 2, lower left). This gives it power and in-
fluence, as it is likely to control the information and
knowledge flow between these two separate groups. In
this network, values of closeness centrality are evenly
distributed, indicating that most organizations can
quickly obtain and disseminate information (Fig. 2, lower
right).
Discussion
The increasing circulation of CHIKV has promoted sci-
entific development towards disease control. Although
the CHIKV mostly affects African and Asian countries,
Fig. 1 Global network of countries conducting research on vaccines against Chikungunya. Each node represents a country and two countries
were considered connected if its organizations shared the authorship of a paper. The size of the nodes indicates their degree centrality and the
thickness of links indicates the intensity of collaboration between two nodes. The nodes are color-coded by continent – European continent
(blue), North America (pink), Asia (green), Africa (yellow), South America (grey) or Australia/Oceania (orange)
Table 2 Degree centrality and number of publications in the
global network of countries conducting research on vaccines
against the Chikungunya virus
Country Rank Degree centralitya Number of publications
France 1 0.702 22
United States 2 0.567 59
Spain 3 0.405 7
aCentrality values were normalized in accordance with the size of the network
Table 3 Metrics of the global organizational network of
research on vaccines against the Chikungunya virus
Network metrics Value
Number of nodes (organizations) 205
Number of links 493
Density 0.048
Centralization 0.128
Number of communities 40
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Table 4 Top five central organizations in the global network of research on vaccines against the Chikungunya virus
Organization (rank) Degree centralitya Organization (rank) Betweeness centralitya Organization (rank) Closeness centralitya
University of Texas 0.117 University of Texas 0.188 University of Texas 0.402
National University of
Singapore
0.107 CEA 0.132 Queensland Institute of
Medical Research
0.392





0.083 University of Munich 0.077 INRA 0.355
CEA 0.083 Osaka University 0.073 University of Queensland 0.354
aCentrality values were normalized in accordance with the size of the network
ASTAR, Singapore Agency for Science, Technology and Research; CEA, French Alternative Energies and Atomic Energy Commission; INRA, French National Institute
for Agricultural Research
Fig. 2 Global network of organizations that perform research on vaccines against the Chikungunya virus. Each node is an organization and two
organizations were considered connected if its members shared the authorship of a paper. The thickness of links indicates the intensity of
collaboration between two nodes and the size of the nodes indicates their degree centrality (top image), betweeness centrality (lower left) and
closeness centrality (lower right). Node color indicates whether the organizations is a university (pink), research institute (green), industry (yellow),
hospital or medical centre (blue) or other (grey). The top five organizations with highest centrality according to each metric are labelled. For
visualization purposes, only the largest component is shown
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there is a real possibility that it might reach regions of
Europe and the Americas. Several factors influenced this
global epidemic, including the increased volume of trav-
ellers, the widening geographic distribution of the mos-
quito vectors, the susceptibility of mosquitoes in non-
endemic regions and the occurrence of autochthonous
outbreaks [45].
Prior to 2004, the CHIKV was a relatively neglected
and understudied pathogen, but it has been the focus of
intense study in recent years [46, 47]. Even though the
research and development of CHIKV vaccines began as
early as the 1970s, interest and efforts waned until the
recent re-emergence of the disease. Currently, no li-
censed vaccine against CHIKV is commercially available,
but numerous candidates are under study.
In this analysis, the presence of France, the United
States and Spain as most central in the research network
reflects their scientific commitment with global health is-
sues and the increasing trend of high-income countries to
conduct research on diseases that used to be restricted to
developing countries. After the 2005 and 2006 outbreaks
on La Réunion, French researchers and institutes have
published most CHIKV papers, but other countries are
now paying close attention as well, as they, too, are at risk.
The participation of the industry in the organizational
network (10.7%) for research on vaccines against the
CHIKV reflects the economic interest in this area and
highlights the influence of academic research in the indus-
try, especially in the pharmaceutical setting. Similar levels
of industry engagement in research networks has been re-
ported in the area of infection and immunity [48]. As
product development processes often rely on academic re-
search to evolve and develop new ideas and techniques,
networking can help companies to identify technological
trends and potential partners for cooperation.
The University of Texas, top ranking in the three cen-
trality measures evaluated, is one of the Centres of Ex-
cellence of the Global Virus Network, recently engaged
in drug and vaccine development for CHIKV [49]. The
University of Texas is also working on a live-attenuated
vaccine with support from a large Japanese pharmaceut-
ical company [47]. The presence of two S&T organiza-
tions from Singapore as central in this network could
reflect the resurgence of the CHIKV experienced by the
country in recent years [50]. ASTAR researchers to-
gether with CEA members are also part of the Integrated
Chikungunya Research consortium network, which has
recently developed a vaccine against the CHIKV already
tested in a rodent model.
The analysis conducted in CHIKV vaccines revealed a
good approximation of the research network structure
and key players involved, which can help to indicate di-
rections for further investigation. The relatively small
and young research community is likely to evolve to a
more stable network configuration in the following
years, opening the potential for further in-depth analysis
of the organizations and researchers involved. The ana-
lysis of different time intervals could provide insights on
the dynamics of the research network. The integration
of other data sources can add a more extensive perspec-
tive on the vaccine development community.
Currently, there is an emerging trend to use SNA for
research policy recommendations [9, 10, 27]. Although
there is still limited evidence regarding the effectiveness
of SNA-based policies, the results presented herein in-
form policymakers on several relevant issues: (1) there is
a global network fragmentation, indicating a need for
consolidating collaboration; (2) the most central coun-
tries are high-income economies, revealing the need for
their collaboration with low- and middle-income coun-
tries for research capacity strengthening; and (3) the
identification of central organizations, which can act as
sources of information on technology trends, is relevant
to identify potential partners for global alliances and
support strategic decisions on public health investments.
More general policy-relevant questions related to the
results are open for discussion: To what extent should
organizations focus their research efforts on one or two
partners as opposed to collaborating with several differ-
ent ones? How do local research settings influence inter-
national collaboration? How to reinforce collaboration
between universities and industries? Who are the central
researchers most likely to sustain networking and assist
in guiding research policies?
Conclusions
Co-authorship network analysis is a powerful method of
retrieving information for health studies. This method
contributes in innovative ways to the evaluation of the
collaborative behaviour of researchers, organizations and
countries, by revealing the cooperation structure com-
bined with information about the centrality of the network
participants. The multitude of applications demonstrates
the versatility of information that can be recovered with
this method and opens new perspectives in the study of
collaboration. It allows to understand the research struc-
ture on specific topics, the evolution of research networks
over time and the participation of a particular organization
or country in a specific network.
Some limitations of this research method have to be
mentioned. The co-authorship data represent only one
of the possible indicators of scientific collaboration. Not
all collaborative efforts result in publications, and not all
co-authored papers necessarily imply collaboration in
the form of knowledge sharing among authors. Still, it is
assumed that, in most cases, co-authorship indicates an
active cooperation between partners beyond the simple
exchange of material or information.
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